FDA Newsroom - U.S. Food and Drug Administration

FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children

The U.S. Food and Drug Administration today called for increased attention to product recall communications

FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies

The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation

CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024

By: Patrizia Cavazzoni, M.D., Director, Center for Drug Research and Evaluation Each year, the U.S.

Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum

By: Dr. Brian King, Director of FDA’s Center for Tobacco Products As Director of the

Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice

By: Justin D. Green, MBA, MDiv., Assistant Commissioner, FDA Office of Criminal Investigations A few